Marshall Wace’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,047
Closed -$190K 2784
2023
Q2
$190K Buy
+25,047
New +$191K ﹤0.01% 2249
2023
Q1
Sell
-306,803
Closed -$3.49M 3206
2022
Q4
$3.49M Buy
306,803
+31,245
+11% +$341K 0.01% 1419
2022
Q3
$2.4M Sell
275,558
-198,632
-42% -$2.06M 0.01% 1888
2022
Q2
$4.72M Buy
+474,190
New +$4.77M 0.01% 1390
2021
Q1
Sell
-23,173
Closed -$420K 2935
2020
Q4
$420K Buy
+23,173
New +$358K ﹤0.01% 1539

Other funds holding PTVE

Marshall Wace's PTVE Position: Q3 2023 in Review

Marshall Wace sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q3 2023, closing a stake of 25,047 shares — an estimated $190K sold.

Marshall Wace first reported a position in PTVE in Q4 2020 and held it in 5 quarters. The position peaked at $4.72M in Q2 2022. 111 funds tracked by Wall St. Rank hold PTVE as of Q3 2023.

  • Marshall Wace reported no remaining Pactiv Evergreen Inc. Common stock position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 25,047 Pactiv Evergreen Inc. Common stock shares in Q3 2023, an estimated $190K.
  • Marshall Wace first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 5 quarters.
  • Marshall Wace's Pactiv Evergreen Inc. Common stock position peaked at $4.72M in Q2 2022.
  • 111 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.